Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Proton Collaborative Group (PCG) is a non-profit clinical research organization and consortium dedicated to advancing the field of proton beam therapy through collaborative research. Founded in 2009, the organization facilitates multi-institutional clinical trials and maintains a comprehensive prospective registry to track patient outcomes across various cancer types. PCG brings together leading proton therapy centers to establish evidence-based protocols and define the clinical benefits of proton radiation compared to traditional photon-based treatments. By collecting large-scale data on toxicity and efficacy, PCG aims to optimize treatment delivery and improve the standard of care for oncology patients worldwide.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Proton Collaborative Group.